Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer
基于转化模型的证据表明,在非小细胞肺癌中,标准治疗药物联合抗microRNA-155可增强疗效
期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-024-02060-5
Dogra, Prashant; Shinglot, Vrushaly; Ruiz-Ramírez, Javier; Cave, Joseph; Butner, Joseph D; Schiavone, Carmine; Duda, Dan G; Kaseb, Ahmed O; Chung, Caroline; Koay, Eugene J; Cristini, Vittorio; Ozpolat, Bulent; Calin, George A; Wang, Zhihui